Form 8-K - Current report:
SEC Accession No. 0001104659-23-059138
Filing Date
2023-05-11
Accepted
2023-05-11 16:10:15
Documents
13
Period of Report
2023-05-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2315505d1_8k.htm   iXBRL 8-K 37682
  Complete submission text file 0001104659-23-059138.txt   262411

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vacc-20230511.xsd EX-101.SCH 3556
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vacc-20230511_def.xml EX-101.DEF 27182
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vacc-20230511_lab.xml EX-101.LAB 37223
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vacc-20230511_pre.xml EX-101.PRE 25804
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2315505d1_8k_htm.xml XML 5279
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Vaccitech plc (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 23911080
SIC: 2834 Pharmaceutical Preparations